Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 19, 2002 - Issue 5
Submit an article Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 685-692 | Published online: 29 Sep 2008

  • 9-nitrocamptothecin liposome aerosol: lack of subacute toxicity in dogs. GILBERT, B. E., SERYSHEV, A., KNIGHT, V., and BRAYTON, C. Inhalation Toxicology, 2002, 14, 185-197.
  • A liposome-based therapeutic vaccine against beta-amyloid plaques on the pancreas of transgenic NORBA mice. NICOLAU, C., GREFERATH, R., BALABAN, T. S., LAZARTE, J. E., and HOPKINS, R. J. Proceedings of the National Academy of Sciences (USA), 2002, 99, 2332-2337.
  • A new model using liposomes that allow to distinguish between absorption and oxidative properties of sunscreens. TRAN, C., SORG, O., CARRAUX, P., DIDIERJEAN, L., SIEGENTHALER, G., FALSON, F., and SAURAT, J. H. Photochemistry and Photobiology, 2002, 75, 1-5.
  • A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling. DESAI, T. R., WONG, J. P., HANCOCK, R. E. W., and FINUY, W. H. Journal of Pharmaceutical Sciences, 2002, 91, 482-491.
  • A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres. LIU, Z., CHEUNG, R., Wu, X. Y., BALLINGER, J. R., BENDAYAN, R., and RAUTH, A. M. Journal of Controlled Release, 2001, 77, 213-224.
  • Acute effect of tetrandrine pulmonary targeting microspheres on hypoxic pulmonary hypertension in rats. CHENG, D., CHEN, W. B., and Mo, X. N. Chinese Medical Journal, 2002, 115, 81-83.
  • Adsorption of DOPC onto Hg from the G vertical bar S interface and from a liposomal suspension. STAUFFER, V., STOODLEY, R., AGAK, J. O., and BIKZOTTO, D. Journal of Electroanalytical Chemistry, 2001, 516, 73-82.
  • Adsorption properties of zeolite-containing microspheres and FCC catalysts based on Ukrainian kaolin. PATRYLAK, L., LIKHNYOVSKYI, R., VYPYRAYLENKO, V., LEBODA, R., SKUBISZEWSKA-ZIEBA, J., and PATRYLAK, K. Adsorption Science & Technology, 2001, 19, 525-540.
  • Advanced sunscreens: UV absorbers entrapped in sol-gel glass microcapsules. ROTTMAN, C., GANS, O., BIAGINI, F., and LAPIDOT, N. Journal of Sol-Gel Science and Technology, 2002,23, 268- 270.
  • Alginate microspheres in an endodontic filling material. MARESCA, B., BREGNI, C., MONJES, J. F., FRIAS, M., LLIMOS, A. C. R., and SABATE, R. Journal of Dental Research, 2001, 80, 949-949.
  • AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. ADLER-MOORE, J., and PROFFITT, R. T. Journal of Antimicrobial Chemotherapy, 2002, 21-30.
  • Anacardic acid-mediated changes in membrane potential and pH gradient across liposomal membranes. TOYOMIZU, M., OKAMOTXD, K., AKIBA, Y., NAKATSU, T., and KONISHI, T. Biochimica et Biophysica Acta-Biomembranes, 2002, 1558, 54-62.
  • Antioxidant activity of phosvitin in phosphatidylcholine liposomes and meat model systems. LEE, S. K., HAN, J. H., and DECKER, E. A. Journal of Food Science, 2002, 67, 37-41.
  • Antioxidative activity of whey protein hydrolysates in a liposomal system. PENA-RAMOS, E. A., and XIONG, Y. L. Journal of Dairy Science, 2001, 84, 2577-2583.
  • Application of a hydrodynamic model to microencapsulation by coacervation. DOBETTI, L., and PANTALEO, V'. Journal of Microencapsulation, 2002, 19, 139-151.
  • Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsono- lipid-containing liposomes on the viability of cancer and normal cells in culture. GORTZI, O., PAPADIMITRIOU, E., KONTOYANNIS, C. G., ANTIMISIARIS, S. G., and IOANNOU, P. V. Pharmaceutical Research, 2002, 19, 79-86.
  • Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. YOTNDA, P., CHEN, D. H., CHIU, W., PIEDRA, P. A., DAVIS, A., TEMPLETON, N. S., and BRENNER, M. K. Molecular Therapy, 2002, 5, 233-241.
  • Biovailability study of dried microencapsulated ferrous sulfate SFE 171-by means of the prophylactic-preventive method. LYSIONEK, A. E., ZUBILLAGA, M. B., SALGUEIRO, M. J., CARO, R. A., WEILL, R., and BOCCIO, J. R. Journal of Trace Elements in Medicine and Biology, 2001,15,255-259.
  • Cd(II) removal from human plasma by cysteine-immobilized PHEMA microspheres. BEKTAS, S., DISBUDAK, A., DENIZLI, A., and GENC, O. Trace Elements and Electrolytes, 2002, 19, 26-32.
  • Ceramic microspheres. SHINBACH, M. P. Journal of Cosmetic Science, 2000, 51, 328-329.
  • Characterization of a novel pH-sensitive peptide that enhances drug release from folatetargeted liposomes at endosomal pHs. TURK, M. J., REDDY, J. A., CHMIELEWSKI, J. A., and Low, P. S. Biochimica et Biophysica Acta-Biomembranes, 2002, 1559, 56-68.
  • Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. SONG, L. Y., AHKONG, Q. F., RONG, Q., WANG, Z., ANSELL, S., HOPE, M. J., and MUI, B. Biochimica et Biophysica Acta-Biomembranes, 2002, 1558, 1-13.
  • Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. KOVACS, A. F., and TUROWSKI, B. Oral Oncology, 2002, 38, 87-95.
  • Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents. SZEBENI, J. Critical Reviews in Therapeutic Drug Carrier Systems, 2001, 18, 567-606.
  • Composite coatings with microcapsules. DIETZ, A., JOBMANN, M., and RAER, G. Material Wissenschaft und Werkstofftechnik, 2000, 31, 612-615.
  • Congo Red attached monosize poly(HEMA-co-MMA) microspheres for use in reversible enzyme immobilisation. YAVUZ, H., BAYRAMOGLU, G., KACAR, Y., DENIZLI, A., and ARICA, M. Y. Biochemical Engineering Journal, 2002, 10, 1-8.
  • Control over PEGylated-liposome aggregation by NeutrAvidin-biotin interactions investigated by photon correlation spectroscopy. VERMEITE, P., TAYLOR, S., DUNSTAN, D., and MEAGHER, L. Langmuir, 2002, 18, 505-511.
  • Copper-induced peroxidation of liposomal palmitoyllinoleoylphosphatidylcholine (PLPC), effect of antioxidants and its dependence on the oxidative stress. BITTNER, O., GAL, S., PINCHUK, I., DANINO, D., SHINAR, H., and LICHTENBERG, D. Chemistry and Physics of Lipids, 2002, 114, 81-98.
  • Cross-linked beta-cyclodeztrin microcapsules. D. Retarding effect on drug release through semi-permeable membranes. PARIOT, N., EDWARDS-LEVY, F., ANDRY, M. C., and LEVY, M. C. International Journal of Pharmaceutics, 2002,232, 175-181.
  • Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin A encapsulated in microspheres. SEO, J. Y., SEONG, S. Y., AHN, B. Y., KWON, I. C., CHUNG, H., and JEONG, S. Y. Infection and Immunity, 2002, 70, 1143-1149.
  • Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. KUMBAR, S. G., KULKARNI, A. R., and AMINABHAVI, T. M. Journal of Microencapsulation, 2002, 19, 173-180.
  • Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. MA, B., SEYMOUR, J. F., JANUSZEWICZ, H., and SUVIN, M. A. Leukemia & Lymphoma, 2001, 42, 1393-1399.
  • Determination of liposome/water partition coefficients of organic acids and bases by solidphase microextraction. ESCHER, B. I., BERG, M., MUHLEMANN, J., SCHWARZ, M. A. A., HERMENS, J. L. M., VAES, W. H. J., and SCHWARZENBACH, R. P. Analyst, 2002, 127, 42-48.
  • Determination of surface free energy of interactive dry powder liposome formulations using capillary penetration technique. DESAI, T. R., Li, D. Q., FINLAY, W. H., and WONG, J. P. Colloids and Surfaces B-Biointerfaces, 2001, 22, 107-113.
  • Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. ABERTURAS, M. R., MOLPECERES, J., GUZMAN, M., and GARCIA, F. Journal of Microencapsulation, 2002, 19, 61-72.
  • Development of liposome immunoassay with high sensitivity by using antibody-coupled large unilamellar vesicles encapsulating horseradish peroxidase. KUMADA, Y., TOMIOKA, K., and KATOH, S. Kagaku Kogaku Ronbunshu, 2002, 28, 77-81.
  • Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. HICKEY, T., KREUTZER, D., BURGESS, D. J., and MOUSSY, F. Biomaterials, 2002, 23, 1649-1656.
  • Differential pulse voltammetric determination of traces of hydrazine using magnetic microspheres. YANG, M., and Li, H. L. Mikrochimica Acta, 2002, 138, 65-68.
  • Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. MARINA, N. M., COCHRANE, D., HARNEY, E., ZOMORODI, K., BLANEY, S., WINICK, N., BERNSTEIN, M., and LINK, M. P. Clinical Cancer Research, 2002, 8, 413-418.
  • Dynamics of disperse systems containing a gas mixture and hollow selectively permeable microspheres. FOMIN, V. M., and DOLGUSHBV, S. V. Doklady Physics, 2001, 46, 900-903.
  • Effect of cholesterol liposomes on calcium mobilization in muscle cells from the rabbit sphincter of Oddi. WANG, X. J., WEI, J. G., WANG, C. M., WANG, Y. C., Wu, Q. Z., Xu, J. K., and YANG, X. X. World Journal of Gastroenterology, 2002, 8, 144-149.
  • Effect of cholesterol on egg yolk phosphatidylcholine peroxidation in multilamellar liposomes. FILIPEK, J., UHRIKOVA, D., SLOSARCIK, P., and BALGAVY, P. Pharmazie, 2001, 56, 953- 957.
  • Effect of dendrimer on entrapment and release of bioactive from liposomes. KHOPADE, A. J., CARUSO, F., TRIPATHI, P., NAGAICH, S., and JAIN, N. K. International Journal of Pharmaceutics, 2002,232, 157-162.
  • Effects of aldehydes and methods of cross-linking on properties of calcium alginate microspheres prepared by emulsiflcation. CHAN, L. W., and HENG, P. W. S. Biomaterials, 2002, 23, 1319-1326.
  • Effects of counterions on molecular transport across liposome bilayer: probed by second harmonic generation. SHANG, X. M., LIU, Y., YAN, E., and EISENTHAL, K. B. Journal of Physical Chemistry B, 2001, 105, 12816-12822.
  • Effects of intraperitoneal administration of liposomes and methods of preparing liposomes for local therapy. SADZUKA, Y., HIRANTA, R., and SONOBE, T. Toxicology Letters, 2002, 126, 83-90.
  • Efficacy and safety of a novel long-acting risperidone microspheres formulation. KANE, J. M., EERDEKENS, M., KEITH, S. J., LESENT, M., KARCHER, K., and LINDENMAYER, J. P. Schizophrenia Research, 2002, 53, 174.
  • Efficacy and safety of long-acting risperidone microspheres and risperidone oral tables. CHUE, P., EERDBKENS, M., AUGUSITNS, I., LACHAUX, B., MOLCAN, P., ERIKSSON, L., PREIORIUS, H., and DAVID, A. Schizophrenia Research, 2002, 53, 174-175.
  • Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes. ISHIDA, T., TAKANASHI, Y., Doi, H., YAMAMOTO, I., and KIWADA, H. International Journal of Pharmaceutics, 2002, 232, 59-67.
  • Enhancement of gene transduction efficiency in cancer cells using cationic liposome with hyperthermia. MUSHIAKE, H., AOE, M., WASHIO, K., ANDOU, A., and SHINHZU, N. Acta Medico Okayama, 2002, 56, 35-42.
  • Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation. GENTA, I., PERUGINI, P., PAVANEITO, F., MACULOTTI, K., MODENA, T., CASADO, B., LUPI, A., IADAROLA, P., and CONTI, B. Journal of Controlled Release, 2001, 77, 287-295.
  • Enzyme-activated targeting of liposomes. MEERS, P. Advanced Drug Delivery Reviews, 2001, 53, 265-272.
  • Extraction mechanism of rare metals with microcapsules containing organophosphorus compounds. KAMIO, E., MATSUMOTO, M., and KONDO, K. Journal of Chemical Engineering of Japan, 2002, 35, 178-185.
  • Extraction of metal cations by polyterephthalamide microcapsules containing a poly(acrylic acid) gel. LAGUECIR, A., ERNST, B., FRERB, Y., DANICHER, L., and BURGARD, M. Journal of Microencapsulation, 2002, 19, 17-28.
  • Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation. VANDENBERG, G. W., DROLET, C., SCOTT, S. L., and DE LA NOUE, J. Journal of Controlled Release, 2001, 77, 297-307.
  • Formation mechanism of carbon-nanocapsules and -nanoparticles based on the in-titu observation. YASUDA, A., KAWASE, N., BANHART, F., MIZUTANI, W., SHINHZU, T., and TOKUMOTO, H. Journal of Physical Chemistry B, 2002, 106, 1247-1251.
  • Gastro-resistant microspheres containing ketoprofen. PALMIERI, G. F., BONACUCINA, G., Di MARTINO, P., and MARTELLI, S. Journal of Microencapsulation, 2002, 19, 111-119.
  • Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes. KIM, H. S., and PARK, Y. S. Cancer Gene Therapy, 2002, 9, 173-177.
  • Glutathione-loaded poly(isobutylcyanoacrylate) nanoparticles and liposomes: comparative effects in murine erythroleukaemia and macrophage-like cells. GATE, L., VAUHVIER, C., COUVREUR, P., TEW, K. D., and TAPIERO, H. STP Pharma Sciences, 2001, 11, 355-361.
  • Hyperflne and magnetic characterization of Fe particles hosted in carbon nanocapsules. COAQUIRA, J. A. H., RECHENBERG, H. R., MARQUINA, C., IBARRA, M. R., BENITO, A. M., MASER, W., MUNOZ, E., and MARTINEZ, M. T. Hyperfine Interactions, 2001, 134, 103-108.
  • IgG(l)-glycolipidic LB films obtained by vertical deposition of an interfacial film formed through proteo-liposome spreading at the air/water interface. GIRARD-EGROT, A. P., CHAUVET, J. P., BOULLANGER, P., and COULET, P. R. Colloids and Surfaces B-Biointerfaces, 2002, 23, 319-325.
  • Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone. GOKHALB, P. C., PEI, J., ZHANG, C. B., AHMAD, I., RAHMAN, A., and KASID, U. Anticancer Research, 2001, 21, 3313-3321.
  • Improvement in the viability of cryopreserved cells by microencapsulation. MATSUMOTO, Y., MORINAGA, Y., UJIHIRA, M., OKA, K., and TANISHITA, K. JSME International Series C- Mechanical Systems Machine Elements and Manufacturing, 2001, 44, 937-945.
  • In vivo applications of PEG liposomes: unexpected observations. LAVERMAN, P., BOERMAN, O. C., OYEN, W. J. G., CORSTENS, F. H. M.,and STORM, G. Critical Reviews in Therapeutic Drug Carrier Systems, 2001,18, 551-566.
  • In-vitro cytotoxic/cytostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines. MASWADEH, H., DEMEI-ZOS, C., DIMAS, K., LOUKAS, Y. L., GEORGOPOULOS, A., MAVROMOUSTAKOS, T., and PAHAIOANNOU, G. T. Journal of Pharmacy and Pharmacology, 2002, 54, 189-196.
  • Incorporation of alpha-tocopherol in marine lipid-based liposomes: in vitro and in vivo studies. NACKA, F., CANSBLL, M., MELKARD, P., and COMBE, N. Lipids, 2001, 36, 1313-1320.
  • Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-captur- ing nanospheres in mice. KAWAMURA, M., NAITO, T., UENO, M., AKAGI, T., HIRAISHI, K., TAKAI, I., MAKINO, M., SERIZAWA, T., SUGIMURA, K., AKASHI, M., and BABA, M. Journal of Medical Virology, 2002, 66, 291-298.
  • Influence of injection site, microvascular pressure and ultrasound variables on microbubble- mediated delivery of microspheres to muscle. SONG, J., CHAPPELL, J. C., Qi, M., VANGIESON, E. J., KAUL, S., and PRICE, R. J. Journal of the American College of Cardiology, 2002,39,726-731.
  • Interaction of phosphatidyl choline based liposomes functionalized at the interface with adenine and barbituric acid moieties. SIDERATOU, Z., TSIOURVAS, D., and PALEOS, C. M. Langmuir, 2002, 18, 829-835.
  • Interleukin-2 liposomes for primary immune deficiency using the aerosol route. TEN, R. M., ANDERSON, P. M., ZEIN, N. N., TEMESGEN, Z., CLAWSON, M. L., and WEISS, W. International Immunopharmacology, 2002, 2, 333-344.
  • Intratracheal administration of free and liposomal tobramycin in an experimental model of chronic lung infection in rats: efficacy against Burkholderia cepacia. MARIER, J. F., DUCHARME, M. R., DUMOULIN, Y., and BELLEMARE, M. Clinical Pharmacology & Therapeutics, 2002, 71, P32.
  • Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. BOCHOT, A., FATTAL, E., BOUTET, V., DEVERRE, J. R., JEANNY, J. C., CHACUN, H., and COUVREUR, P. Investigative Ophthalmology & Visual Science, 2002, 43, 253-259.
  • Investigation on preparation and protein release of biodegradable polymer microspheres as drug-delivery system. ZHOU, S. B., DENG, X. M., YUAN, M. L., and Li, X. H. Journal of Applied Polymer Science, 2002, 84, 778-784.
  • Light trapped in a photonic dot: microspheres act as a cavity for quantum dot emission. ARTEMYEV, M. V., WOGGON, U., WANNBMACHER, R., JASCHINSKI, H., and LANGBEIN, W. Nano Letters, 2001, 1, 309-314.
  • Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. CAGNONI, P. J. Journal of Antimicrobial Chemotherapy, 2002, 81-86.
  • Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. KOULOULIAS, V. E., DARDOUFAS, C. E., KOUVARIS, J. R., GENNATAS, C. S., POLYZOS, A. K., GOGAS, H. J., SANDILOS, P. H., UZUNOGLU, N. K., MAIAS, E. G., and VIAHOS, L. J. Clinical Cancer Research, 2002, 8, 374-382.
  • Liposomal doxorubicin significantly reduces cardiotoxicity in advanced breast cancer patients. [ANON]. Oncology-Nets York, 2001, 15, 1135-1135.
  • Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats. ALEMDAR, A. Y., BAKER, K. A., SADI, D., MCALlSTER, V. C., and MENDEZ, I. Experimental Neurology, 2001, 172, 416-424.
  • Liposomes (a review)-Part two: drug delivery systems. CHRAI, S. S., MURARI, R., and AHMAD, I. Biopharm-The Applied Technologies of Biopharmaceutical Development, 2002, 15, 40.
  • Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. GLOGARD, C., STCNSRUD, G., HOVLAND, R., FOSSHEIM, S. L., and KLAVENESS, J. International Journal of Pharmaceutics, 2002, 233, 131-140.
  • Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency. DASS, C. R., WALKER, T. L., and BUR-ION, M. A. Drug Delivery, 2002, 9, 11-18.
  • Long-lasting cardiovascular effects of liposome-entrapped angiotensin-(l-T) at the rostral ventrolateral medulla. SILVA-BARCELLOS, N. M., FREZARD, F., CALIGIORNE, S., and SANHXDS, R. A. S. Hypertension, 2001, 38, 1266-1271.
  • Long-term safety of long-acting risperidone microspheres. EERDEKENS, M., FLKISCHHACKER, W. W., XIE, Y., and GEFVERT, O. Schizophrenia Research, 2002, 53, 174.
  • Microcapsule for adsorption and recovery of cadmium(II) ion. SATTO, T., and TORII, S. Separation Science and Technology, 2002, 37, 77-87.
  • Microencapsulation experts aid manufacturer of pet foods. [ANON]. R&D Magazine, 2001, 43, 125.
  • Microencapsulation facility opens. [ANON]. Chemical Engineering Progress, 2002, 98, 20.
  • Microencapsulation of water-soluble herbicide by interfacial reaction. II. Release properties of microcapsules. YEOM, C. K., KIM, Y. H., and LEE, J. M. Journal of Applied Polymer Science, 2002,84,1025-1034.
  • Microencapsulation protects immunoglobulin in yolk (IgY) specific against Helicobacter pylori urease. CHANG, H. M., LEE, Y. C., CHEN, C. C., and To, Y. Y. Journal of Food Science, 2002,67,15-20.
  • Microspherical lasing of an erbium-ion-doped glass particle. FUJIWARA, H., and SASAKI, K. Japanese Journal of Applied Physics Part 2-Letters, 2002, 41, L46.
  • Mitochondria! creatine kinase binding to liposomes and vesicle aggregation: effect of cleavage by proteinase K. GRANJON, T., VIAL, C., BUCHET, R., and VACHERON, M. J. Journal of Protein Chemistry, 2001, 20, 593-599.
  • Modeling of the formation kinetics of polyurea microcapsules with size distribution by interfacial polycondensation. KUBO, M., HARAUA, Y., KAWAKATSU, T., and YONEMOTO, T. Journal of Chemical Engineering of Japan, 2001, 34, 1506-1515.
  • Modulation of murine liver macrophage clearance of liposomes by diethylstilbestroL The effect of vesicle surface charge and a role for the complement receptor Mac-1 (CDl Ib/ CD 18) of newly recruited macrophages in liposome recognition. MOGHIMI, S. M., and PATEL, H. M. Journal of Controlled Release, 2002, 78, 55-65.
  • MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitro. HUNGER, C. M., JAHNKE, A., STANGE, J., DE Vos, P., and HOPT, U. T. Artfficial Organs, 2002, 26, 111-116.
  • Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens. MASCDA, K., HORIE, K., SUZUKI, R., YOSHIKAWA, T., and HIRANO, K. Microbiology and Immunology, 2002, 46, 55-58.
  • Oxygen profile of microencapsulated islets: Effect of immobilised hemoglobin in the alginate matrix. SCHREZENMEIR, J., HYDER, A., VREDEN, M., LAUE, C., and MUELLER-MESER, W. Transplantation Proceedings, 2001, 33, 3511-3516.
  • P-glycoprotein inserted in planar lipid bilayers formed by liposomes opened on amorphous carbon and Langmuir-Blodgett monolayer. DIOCIAIUTI, M., MOLINARI, A., RUSPANTINI, I., GAUDIANO, M. C., IPPOLITI, R., LENDARO, E., BORDI, F., CHISTOLINI, P., and ARANCIA, G. Biochimia et Biophysica Acta-Biomembranes, 2002, 1559, 21-31
  • Palladium nanoparticle catalyst prepared in poly(acrylic acid)-lined channels of diblock copolymer microspheres. Lu, Z. H., LIU, G. J., PHILLIPS, H., HILL, J. M., CHANG, J., and KYDD, R. A. Nona Letters, 2001, 1, 683-687.
  • pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. HONG, M. S., LIM, S. J., OH, Y. K., and KIM, C. K. Journal of Pharmacy and Pharmacology, 2002, 54, 51-58.
  • Pharmacokinetic behaviour of cisplatin in peritoneal fluid after intraperitoneal administration of cisplatin-loaded microspheres. TANTURA, T., IMAI, J., MATSUKAWA, Y., HORIKIRI, Y., SUZUKI, T., YOSHINO, H., and IKE, S. Journal of Pharmacy and Pharmacology, 2001, 53, 1331- 1339.
  • Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. BEKERSKY, I., FIELDING, R. M., DRESSIJBR, D. E., LEE, J. W., BUELL, D. N., and WALSH, T. J. Antimicrobial Agents and Chemotherapy, 2002, 46, 828-833.
  • Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS- related Kaposi sarcoma. ROSENTHAL, E., POIZOT-MARTIN, I., SAINT-MARC, T., SPANO, J. P., and CACOUB, P. American Journal of Clinical Oncology-Cancer Clinical Trials, 2002, 25, 57-59.
  • Phospholipid coated poly(lactic acid) microspheres for the delivery of LHRH analogues. RASIEL, A., SHESKIN, T., BERGELSON, L., and DOMB, A. J. Polymers for Advanced Technologies, 2002, 13, 127-136.
  • Phototriggering of liposomal drug delivery systems. SHUM, P., KIM, J. M., and THOMPSON, D. H. Advanced Drug Delivery Reviews, 2001, 53, 273-284.
  • Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocel- lular carcinoma. SCHMIDINGER, M., WENZEL, C., LOCKER, G. J., MUEHLBACHER, F., STEININGER, R., GNANT, M., CREVENNA, R., BUDINSKY, A. C., and STEGER, G. G. British Journal of Cancer, 2001,85,1850-1852.
  • Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate. BEKERSKY, I., FIELDING, R. M., DRESSIJBR, D. E., LEE, J. W., BUELL, D. N., and WALSH, T. J. Antimicrobial Agents and Chemotherapy, 2002, 46, 834-840.
  • Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or flbrinogen: approach to platelet substitutes. NISHIYA, T., KAINOH, M., MURATA, M., HANDA, M., and IKEDA, Y. Artificial Cells, Blood Substitutes and Immobilization Biotechnology, 2001,29,453-463.
  • PMMA microcapsules containing water-soluble dyes obtained by double emulsion/solvent evaporation technique. ZVDOWICZ, N., NZINTBA-GANYANAD, E., and ZYDOWICZ, N. Polymer Bulletin, 2002, 47, 457-463.
  • Polyvinylamine hydrochloride-based microcapsules: polymer synthesis, permeability and mechanical properties. GRIGORESCU, G., REHOR, A., and HUNKELER, D. Journal of Microencapsulation, 2002, 19, 245-259.
  • Potentiation of liposome-induced complement activation by surface-bound albumin. SAVAY, S., SZEBENI, J., BARANYI, L., and ALVINC, C. R. Biochimica et Biophysica Acta--Biomembranes, 2002, 1559, 79-86.
  • Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. CHOI, H. S., SEO, S. A., KHANC, G., RHEE, J. M., and LEE, H. B. International Journal of Pharmaceutics, 2002,234, 195-203.
  • Preparation and characterization of triclosan-containing microcapsules by complex coacer- vation. KIM, J. C., SONG, M. E., LEE, E. J., PARK, S. K., RANG, M. J., and AHN, H. J.Journal of Dispersion Science and Technology, 2001, 22, 591-596.
  • Preparation and stability of agarose microcapsules containing BCG. ESQUISABEL, A., HERNANDEZ, R. M., IGARTUA, M., GASCON, A. R., CALVO, B., and PEDRAZ, J. L. Journal of Microencapsulation, 2002, 19, 237-244.
  • Preparation of micron-sized monodispersed thermoresponsive core-shell microcapsules. CHU, L. Y., PARK, S. H., YAMAGUCHI, T., and NAKAO, S. Langmuir, 2002, 18, 1856-1864.
  • Preparation of mono-sized PMMA/liquid crystal microcapsules by solute co-diffusion method. CHO, S. A., PARK, N. H., KIM, J. W., and SUH, K. D. Colloids and Surfaces A- Physicochemical and Engineering Aspects, 2002, 196, 217-222.
  • Preparation of styrene/acrylic acid copolymer microspheres: polymerization mechanism and carboxyl group distribution. WANG, P. H., and PAN, C. Y. Colloid and Polymer Science, 2002,280, 152-159.
  • Preparation, characterization and in vitro drug release of isosorbide dinitrate microspheres. DINARVAND, R., MIRFATTAHI, S., and ATYABI, F. Journal of Microencapsulation, 2002, 19, 73-81.
  • Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly- (ethylene glycol)-modified lipids. Li, W. M., MAYER, L. D., and BALLY, M. B. Journal of Pharmacology and Experimental Therapeutics, 2002, 300, 976-983.
  • Production of glass microspheres using the plasma-spraying method. BESSMERTNYI, V. S., KROKHIN, V. P., LYASHKO, A. A., DRIZHD, N. A., and SHEKHOVTSOVA, Z. E. Glass and Ceramics, 2001,58, 268-269.
  • Proliferation of canine intervertebral disk chondrocytes in three-dimensional alginate microsphere culture. MASUDA, K., MIYABAYASHI, T., MEACHUM, S. H., and EURELL, T. E. Journal of Veterinary Medical Science, 2002, 64, 79-82.
  • Proton-conducting membrane composed of sulfonated polystyrene microspheres, poly(vi- nylpyrrolidone) and poly(vinylidene fluoride). CHEN, N. P., and HONG, L. Solid State Ionics, 2002, 146, 377-385.
  • Quantitative Immunoblot assay for assessment of liposomal antibody conjugation efficiency. KLEGERMAN, M. E., HAMILTON, A. J., HUANG, S. L., TIUKINHOY, S. D., KHAN, A. A., MACDONALD, R. C., and MCPHERSON, D. D. Analytical Biochemistry, 2002, 300, 46-52.
  • Rapid recovery of platelet count following administration of liposome-encapsulated clodro- nate in a mouse model of immune thrombocytopenia. ALVES-ROSA, F., STANGANELLI, C., CABRERA, J., CYMBERKNOP, D., RUBEL, C., VANZULLI, S., VAN ROOIJEN, N., PALERMO, M., and ISI-URIZ, M. A. British Journal of Haematology, 2002, 116, 357-366.
  • Rapid transbilayer movement of spin-labeled steroids in human erythrocytes and in liposomes. MULLER, P., and HERRMANN, A. Biophysical Journal, 2002, 82, 1418-1428.
  • Redirecting adenovirus to pulmonary endothelium by cationic liposomes. MA, Z., Mi, Z., WILSON, A., ALBER, S., ROBBINS, P. D., WATKINS, S., PITT, B., and Li, S. Gene Therapy, 2002,9, 176-182.
  • Release property of temperature-sensitive liposome containing poly(N-isopropylacrylamide). KIM, J. C., and KIM, J. D. Colloids and Surfaces B-Biointerfaces, 2002, 24, 45-52.
  • Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study. PASSAS, A., BUFFELS, R., ANAGNOSTOPOULOS, A., GALOS, E., VADIKOLIA, C., HALOUDIS, P., and KALOYANNIDIS, P. British Journal of Haematology, 2002, 116, 308-315.
  • Scintillation proximity assay using molecularly imprinted microspheres. YE, L., SURUGIU, I., and HAUPT, K. Analytical Chemistry, 2002, 74, 959-964.
  • Selection of structural parameters in developing chemical compositions for glass microspheres. MEDVEDEV, E. F. Glass and Ceramics, 2001, 58, 235-238.
  • Selective in vitro labeling of white blood cells using Tc-99m-labeled liposomes. ANDREOPOULOS, D., KASI, L. P., ASIMACOPOULOS, P. J., JHINGRAN, S. G., COLE, W., YANG, D., and KIM, E. E. Nuclear Medicine and Biology, 2002, 29, 185-190.
  • Selective reduction in type I adenylyl cyclase after microsphere embolism in rat brain. NAGAKURA, A., TAKAGI, N., and TAKEO, S. Neuroscience Letters, 2002, 317, 69-72.
  • Self-assembly of cationic liposomes-DNA complexes: a structural and thermodynamic study by EDXD. CARACCIOLO, G., CAMINITI, R., POZZI, D., FRIELLO, M., BOFFI, F., and CASTELLANO, A. C. Chemical Physics Letters, 2002, 351, 222-228.
  • Single-particle mass spectrometry of polystyrene microspheres and diamond nanocrystals. CAI, Y., PENG, W. P., KUO, S. J., LEE, Y. T., and CHANG, H. C. Analytical Chemistry, 2002,74, 232-238.
  • Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. EL MAGHRABY, G. M. M., WILLIAMS, A. C., and BARRY, B. W. Journal of Pharmacy and Pharmacology, 2001, 53, 1311-1322.
  • Solvent, emulsifler and drug concentration factors in poly(D,L-lactic acid) microspheres containing hezamethylmelamine. HARIHARAN, M., and PRICE, J. C. Journal of Microencapsulation, 2002, 19, 95-109.
  • Specific attachment of aqueous-based microcapsules to macrophages, B cells, and dendritic cells in vitro. BRUBAKER, J. O., MACARTNEY, K. K., SPEAKER, T. J., and OFFIT, P. A. Journal of Microencapsulation, 2002, 19, 213-223.
  • Spectral properties of close-packed monolayers consisting of metal nanospheres. KACHAN, S. M., and PONYAVINA, A. N. Journal of Physics-Condensed Matter, 2002, 14, 103-111.
  • Study on recognition mechanism of molecularly imprinted microsphere synthesized from aqueous solution. LAI, J. P., CAO, X. F., HE, X. W., and Li, Y. Y. Acta Chimica Sinica, 2002, 60, 322-327.
  • Sublytic alterations caused by the nonionic surfactant dodecyl maltoside in stratum corneum lipid liposomes. COCERA, M., LOPEZ, O., CODERCH, L., PARRA, J. L., and DE LA IAEA, A. Langmuir, 2002, 18, 297-300.
  • Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. LESTINI, B. J., SAGNELLA, S. M., Xu, Z., SHIVE, M. S., RICHTER, N. J., JAYASEHARAN, J., CASE, A. J., KOTTKE-MARCHANT, K., ANDERSON, J. M., and MARCHANT, R. E. Journal of Controlled Release, 2002, 78, 235-247.
  • Sustained release of hydrophobic materials from sonochemically prepared bovine serum albumin microcapsules. MAKINO, K., MIZOROGI, T., ANDO, S., TSUKAMOTO, T., and OHSHIMA, H. Colloids and Surfaces B-Biointerfaces, 2002, 23, 59-64.
  • Swelling of oligomeric polystyrene seed particles to prepare porous microspheres using n- hexane as porogen. Ou, J. L., Wu, M. H., and CHEN, H. Journal of Materials Science Letters, 2001,20,2221-2223.
  • Synthesis, characterization, and in vitro release of ibuprofen from poly(MMA-HEMA) copolymeric core-shell hydrogel microspheres for biomedical applications. SIVAKUMAR, M., and RAO, K. P. Journal of Applied Polymer Science, 2002, 83, 3045-3054.
  • Targeting of liposomes to human keratinocytes through adhesive peptides from immuno- globulin domains in the presence of IFN-gamma. JAAFARI, M. R., and FOLDVARI, M. Drug Delivery, 2002, 9, 1-9.
  • Targeting of liposomes to melanoma cells with high levels of ICAM-I expression through adhesive peptides from immunoglobulin domains. JAAFARI, M. R., and FOLDVARI, M. Journal of Pharmaceutical Sciences, 2002, 91, 396-404.
  • Taste masking of diclofenac sodium using microencapsulation. AL-UMRAN, M. F., AL- SUWAYEH, S. A., EL-HELW, A. M., and SALEH, S. I. Journal of Microencapsulation, 2002, 19, 45-52.
  • Ten years experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital. RINGDEN, O. Journal of Antimicrobial Chemotherapy, 2002, 51-55.
  • Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice. JUNG, T., KONEBERG, R., HUNGERER, K. D., and KISSEL, T. International Journal of Pharmaceutics, 2002, 234, 75-90.
  • The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. RADWAN, M. A., and ABOUL- ENEIN, H. Y. Journal of Microencapsulation, 2002, 19, 225-235.
  • The effect of oral valspodar (psc 833), a modulator of multidrug resistance, on the pharma- cokinetics of liposomal doxorubicin. LUM, B. L., CHIN, D. L., CHO, C. D., ADVANI, R., FISHER, G. A., HALSEY, J., and SIKIC, B. I. Clinical Pharmacology Sf Therapeutics, 2002, 71, P48.
  • e influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. MATEOVIC, T., KRIZNAR, B., BOGATAJ, M., and MRHAR, A. Journal of Microencapsulation, 2002, 19, 29-36.
  • The presence of PEG-lipids in liposomes does not reduce melittin binding but decreases melittin-induced leakage. REX, S., BIAN, J., SILVIUS, J. R., and LAECR, M. Biochimica et Biaphysica Acta-Biomembranes, 2002, 1558, 211-221.
  • The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres. CHEN, J., and DAVIS, S. S. Journal of Microencapsulation, 2002, 19, 191-201.
  • The role OfFe3+ on Fe2+-dependent lipid peroxidation in phospholipid liposomes. OHYASHIKI, T., KADOYA, A., and KUSHIDA, K. Chemical & Pharmaceutical Bulletin, 2002, 50, 203-207.
  • Thermosensitive polymer-modified liposomes. KONO, K. Advanced Drug Delivery Reviews, 2001, 53, 307-319.
  • Treatment of microencapsulated beta-galactosidase with ozone: effect on enzyme and microorganism. KWAK, H. S., LEE, J. B., and AHN, J. Asian-Australasian Journal of Animal Sciences, 2002, 15, 596-601.
  • Urea-formaldehyde resin microspheres as a new packing material for liquid chromatog- raphy: Ligand exchange. CHAI, Z. K., ZHANG, X., and SUN, X. F. Journal of Liquid Chromatography & Related Technologies, 2002, 25, 69-81.
  • Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome-cell adhesion. CHANDAROY, P., SEN, A., ALEXANDRIDIS, P., and HUI, S. W. Biochimica et Biophysica Acta-Biomembranes, 2002, 1559, 32-42.
  • UV-induced gelation on nanometer scale using liposome reactor. KAKAKOV, S., KAHOLEK, M., TERAOKA, I., and LEVON, K. Macromolecules, 2002, 35, 1911-1920.
  • Voltammetric studies of the effect of Cisplatin-liposome on HeIa cells. Ci, Y. X., ZHAI, Q., WANG, S., CHANG, W. B., ZHANG, C. Y., MA, H., CHEN, D. Y., ZHAO, M. Z., and Hu, S. W. Talanta, 2001, 55, 693-698.
  • Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. POWERS, J. H., DIXON, C. A., and GOLDBERGER, M. J. New England Journal of Medicine, 2002, 346, 289-290.
  • Water transport and drug release study from cross-linked polyacrylamide grafted guar gum hydrogel microspheres for the controlled release application. SOPPIRNATH, K. S., and AMINABHAVI, T. M. European Journal of Pharmaceutics and Biopharmaceutics, 2002, 53, 87-98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.